Results 41 to 50 of about 482,608 (393)

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms

Platelets, 2018
Essential thrombocythemia (ET) and polycythemia vera (PV) are myeloproliferative neoplasms (MPN) with an increased risk of arterial and venous thrombosis.
Andréas Perrier-Cornet, Jean-Christophe Ianotto, Fanny Mingant, Maëla Perrot, Eric Lippert, Hubert Galinat   +5 more
doaj   +1 more source

Clinical pictures of phenotypes of intolerance to aspirin and other nonsteroidal anti-inflammatory drugs. Part I

Pediatria i Medycyna Rodzinna, 2014
Clinically, three phenotypes of intolerance to aspirin and other nonsteroidal anti-inflammatory drugs are distinguished: bronchospastic phenotype, urticaria/oedema and chronic hyperplastic eosinophilic sinusitis.
Iwona Grzelewska-Rzymowska, Paweł Górski   +1 more
doaj   +1 more source

The targets of aspirin in bladder cancer: bioinformatics analysis

BMC Urology, 2022
Background The anti-carcinogenic properties of aspirin have been observed in some solid tumors. However, the molecular mechanism of therapeutic effects of aspirin on bladder cancer is still indistinct. We introduced a bioinformatics analysis approach, to
Xiao Li, Yanghao Tai, Shuying Liu, Yating Gao, Kaining Zhang, Jierong Yin, Huijuan Zhang, Xia Wang, Xiaofei Li, Dongfeng Zhang, Dong-feng Zhang   +10 more
doaj   +1 more source

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

New England Journal of Medicine, 2019
BACKGROUND Monotherapy with a P2Y12 inhibitor after a minimum period of dual antiplatelet therapy is an emerging approach to reduce the risk of bleeding after percutaneous coronary intervention (PCI).
R. Mehran, U. Baber, Samin K. Sharma, D. Cohen, D. Angiolillo, C. Briguori, Jin Y Cha, T. Collier, G. Dangas, D. Dudek, V. Džavík, J. Escaned, R. Gil, P. Gurbel, C. Hamm, T. Henry, K. Huber, A. Kastrati, U. Kaul, R. Kornowski, M. Krucoff, V. Kunadian, S. Marx, S. Mehta, D. Moliterno, E. Ohman, K. Oldroyd, G. Sardella, S. Sartori, R. Shlofmitz, P. Steg, G. Weisz, B. Witzenbichler, Ya‐Ling Han, S. Pocock, C. Gibson   +35 more
semanticscholar   +1 more source

Aspirin [PDF]

Journal of Thrombosis and Haemostasis, 2004
Smith JB, Mustard JF, Jilma B, FucksI, VIOLI, Francesco, PIGNATELLI, Pasquale, PULCINELLI, FABIO MARIA, de GaetanoG, Cerletti C, Rosenson SF, Wolff D, Green D, Boss AH, Kensey K.R.   +13 more
  +16 more sources

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

New England Journal of Medicine, 2018
BACKGROUND Diabetes mellitus is associated with an increased risk of cardiovascular events. Aspirin use reduces the risk of occlusive vascular events but increases the risk of bleeding; the balance of benefits and hazards for the prevention of first ...
L. Bowman, M. Mafham, K. Wallendszus, W. Stevens, G. Buck, J. Barton, K. Murphy, Theingi Aung, R. Haynes, J. Cox, A. Murawska, A. Young, M. Lay, Fang Chen, E. Sammons, Emma Waters, A. Adler, J. Bodansky, A. Farmer, R. Mcpherson, A. Neil, D. Simpson, R. Peto, C. Baigent, R. Collins, S. Parish, J. Armitage   +26 more
semanticscholar   +1 more source

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation.

New England Journal of Medicine, 2020
BACKGROUND The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indication for long-term anticoagulation has not been ...
J. Brouwer, V. Nijenhuis, R. Delewi, R. Hermanides, W. Holvoet, C. Dubois, P. Frambach, B. de Bruyne, G. V. van Houwelingen, J. van der Heyden, P. Toušek, F. van der Kley, I. Buysschaert, C. Schotborgh, B. Ferdinande, P. van der Harst, J. Roosen, J. Peper, Frederick W F Thielen, L. Veenstra, D. R. Chan Pin Yin, M. Swaans, B. Rensing, A. W. van ’t Hof, L. Timmers, J. Kelder, P. Stella, J. Baan, J. T. ten Berg   +28 more
semanticscholar   +1 more source

Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA

New England Journal of Medicine, 2018
BACKGROUND Combination antiplatelet therapy with clopidogrel and aspirin may reduce the rate of recurrent stroke during the first 3 months after a minor ischemic stroke or transient ischemic attack (TIA).
S. Johnston, D. Easton, M. Farrant, W. Barsan, R. Conwit, C. Johnston, J. Easton, J. Elm, A. Kim, Anne S. Lindbald, Y. Palesch   +10 more
semanticscholar   +1 more source

Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.

New England Journal of Medicine, 2020
BACKGROUND More information is needed about the long-term effects of low-dose aspirin (≤160 mg) on incident hepatocellular carcinoma, liver-related mortality, and gastrointestinal bleeding in persons with chronic hepatitis B or hepatitis C virus ...
Tracey G. Simon, Ann-Sofi Duberg, S. Aleman, R. Chung, A. Chan, J. Ludvigsson   +5 more
semanticscholar   +1 more source

Aspirin resistance in patients with acute coronary syndrome. Part 2

Кардиоваскулярная терапия и профилактика, 2011
Aim. In patients with acute coronary syndrome (ACS), to investigate the prevalence of aspirin resistance, its clinical features, prognostic effects, and potential correction. Material and methods.
N. S. Frolova, R. M. Shakhnovich, E. M. Kaznacheeva, O. V. Sirotkina, A. B. Dobrovolskyi   +4 more
doaj   +1 more source